The overall objectives of the Phase II effort are to develop additional antibodies against cyclic nucleotides (including cCMP) to compliment the antibodies generated during the fulfillment of prototype non-isotopic immunoassays for the measurement of cyclic nucleotides, and to complete the development of the assays in collaboration with BAbCO's Phase III partner (Boehringer Mannheim).

Project Start
1992-09-30
Project End
1994-09-29
Budget Start
1992-09-30
Budget End
1993-04-30
Support Year
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Berkeley Antibody Company
Department
Type
DUNS #
City
Richmond
State
CA
Country
United States
Zip Code
94806